Unfortunately, NNVC offers both dilution and delay. Float has more than quadrupled, from 20 million to 89 million. With more coming - SeaSide isn't done.
I find it surprising that anyone observes a company (with no revenues) always filing its quarterly reports late, then thinks NNVC will suddenly turn on a dime with its research efforts.
If they can't do the easy things right, don't expect much.
The promises have gone downhill, from "filing an IND soon" to "having a pre-IND meeting soon" to "requesting a pre-IND meeting soon" to I don't know... Post-It notes on the fridge, I guess. Pick up bread, milk, call FDA.
Continued stock dilution and delays as far as the eye can see. IND filing eventually scheduled for 2028... to be pushed back when we get to 2027.
How many more delays are acceptable?